Join the webinar on the acceptability of NDAs/MAAs with only Chinese patients by Western regulatory agencies. More and more data from Chinese patients are used in NDA/MAA submissions, and sometimes, only clinical data from China is provided. Discover the challenges, opportunities, and how PLG will be able to support your clinical trials in China.

Check out the 7th installment of the PLG-Zwiers Product Development webinar series.

 

Dr. Sougat Sarkar
General Manager Clinical Development

Register to our news and events

Go to our Events to register
Go to our News to get insights

Acceptance of NDA’s/ MAA’s with only Chinese patients by Western regulatory agencies